Inactive Instrument
BiVictriX Therapeutics plc Stock
Stocks
BVX
GB00BNXH3K91
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +17.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
CEO | Chief Executive Officer | 39 | 01/01/2016 |
Adrian Howd
DFI | Director of Finance/CFO | 54 | 03/10/2023 |
Alison Halsall
SEC | Corporate Secretary | - | 13/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
BRD | Director/Board Member | 39 | 01/01/2016 |
Susan Lowther
BRD | Director/Board Member | 67 | 22/09/2021 |
William Paris
BRD | Director/Board Member | 75 | 22/09/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/2/24 A | Buy | Director | 20,000 | 0.0242% | ||
| 9/2/24 A | Sell | Director | 20,000 | 0.0242% | ||
| 8/13/24 A | Free | Executive/Senior Manager | 320,000 | 0.3878% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +17.65% | +33.33% | - | - | 10.49M | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +1.03% | +2.73% | +12.31% | +84.00% | 55.53B | |
| +1.48% | +1.72% | +12.98% | +105.14% | 53.03B | |
| -0.65% | -0.36% | +27.31% | +56.54% | 45.99B | |
| -0.41% | -2.72% | +18.11% | +99.28% | 42.45B | |
| +0.45% | +1.03% | +226.83% | +933.38% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +90.26% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | +1.52% | +3.82% | +52.47% | +163.24% | 43.62B | |
| Weighted average by Cap. | -0.00% | +3.13% | +49.54% | +160.89% |
Employees
-
